GTHP — GUIDED THERAPEUTICS INC
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 924515 ·
Last close
$0.25
Market Cap
$23.94M
52W High
$0.54
52W Low
$0.15
ADV30
10,180
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 0 | 0 | -302,000 | -500,000 | 1,604,000 | 369,000 | 6,780,000 |
| Dec 2025 | 590,000 | 458,000 | -710,000 | -1,218,000 | 1,324,000 | 63,000 | 7,330,000 |
| Sep 2025 | 60,000 | 35,000 | -485,000 | -742,000 | 903,000 | 87,000 | 6,549,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,354,000
Investing CF
$0
Financing CF
$1,610,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.04
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-158,068,000
Inventory
$469,000
Receivables
$4,000
ST Investments
—
EBIT TTM
$-2,650,000
Pretax Income TTM
$-3,271,000
Interest Exp TTM
$621,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$650,000
EBITDA
$-1,966,000
Free Cash Flow
$-1,049,000
Enterprise Value
$27,625,338
Total Cash
$12,000
Total Debt
$2,786,000
Shares Out
96,537,349
Trailing EPS
$-0.04
Book Value
$-0.07
ROE
—
ROA
-115.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 767,000 | -2,372,000 | -3,196,000 | 1,324,000 | 7,330,000 | -6,006,000 | -1,068,000 |
| Dec 2024 | 7,000 | -2,108,000 | -2,417,000 | 1,378,000 | 6,267,000 | -4,889,000 | -1,119,000 |
| Dec 2023 | 98,000 | -3,457,000 | -3,489,000 | 1,669,000 | 5,475,000 | -3,806,000 | -1,746,000 |
| Dec 2022 | 13,000 | -3,333,000 | -4,341,000 | 3,366,000 | 6,249,000 | -2,883,000 | -1,479,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BDMD | Baird Medical Investment Holdings Ltd | $24.53M | $0.77 | — |
| RDGL | VIVOS INC | $22.69M | $0.05 | — |
| PLRZ | Polyrizon Ltd. | $25.56M | $10.77 | — |
| ARAY | ACCURAY INC | $26.28M | $0.22 | — |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | $26.51M | $0.86 | — |
News headlines (Yahoo Finance, 1h cache)
Guided Therapeutics Reaches Collaborative Agreement with Türkiye’s Ministry of Health to Become Primary Screening Test for Cervical Cancer
2026-09-09 13:00 · Yahoo
Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor
2026-07-22 13:00 · Yahoo
Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation
2026-07-14 13:00 · Yahoo
Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
2026-06-16 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.